About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Arizona | 16,602 Studies Near You

Clinical TrialsArizona

Clinical Trials in Arizona

Discover 16,602 clinical trials near Arizona. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1981-2000 of 16,602 trials

RecruitingA Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder CancerThis phase I trial evaluates the effects of bicalutamide, compared to no study drug (NSD), on epidermal growth factor receptor (EGFR) protein expression in patients with…NCT05521698·Tucson, Arizona and 5 others CompletedECG App Algorithms Clinical Validation StudyThe purpose of the study is to evaluate the performance of ECG classification algorithms and their ability to classify heart rhythms into multiple categories of rhythms and heart…NCT04247581·Phoenix, Arizona and 3 others CompletedThe OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC StudyThe study is investigating the ability of UroGen's UGN-101 to treat urothelial carcinoma tumors from the upper urinary tract.NCT02793128·Phoenix, Arizona and 23 others

Find Trials by Condition in Arizona

Breast Cancerin Arizona Lung Cancerin Arizona Prostate Cancerin Arizona Colorectal Cancerin Arizona Melanomain Arizona Leukemiain Arizona Lymphomain Arizona Pancreatic Cancerin Arizona Ovarian Cancerin Arizona Brain Cancerin Arizona Diabetes

Data from ClinicalTrials.govTerms

Approved for marketingAn Expanded Access Program to Provide Nintedanib to Patients With Non-IPF ILD Who Have no Alternative Treatment PossibilitiesThis Expanded Access Program is intended to facilitate the availability of OFEV to patients suffering from non Idiopathic Pulmonary Fibrosis-Interstitial Lung Disease (non…NCT03843892·Tucson, Arizona and 5 others

Active not recruitingA Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy ParticipantsThe purpose of this study is to evaluate the safety and reactogenicity of mRNA-1195 in healthy participants.NCT05831111·Anniston, Alabama and 33 others

CompletedStudy of Efficacy and Safety of LNP023 in Primary IgA Nephropathy PatientsThe study is designed as a multicenter, randomized, double-blind, placebo controlled study to demonstrate the superiority of iptacopan (LNP023) at a dose of 200 mg b.i.d. compared…NCT04578834·Glendale, Arizona and 176 others

CompletedA Study To Evaluate the Relative Bioavailability, Food Effect, and Dose Proportionality of a Granule Formulation of Vanzacaftor/Tezacaftor/Deutivacaftor(VNZ/TEZ/D-IVA)The purpose of this study is to evaluate the relative bioavailability, food effect, and dose proportionality of a granule formulation of VNZ/TEZ/D-IVA.NCT06299709·Tempe, Arizona

CompletedHerpeVac Trial for Young WomenThe primary purpose of this study is to see if a herpes vaccine may prevent genital herpes disease in women who are not infected.NCT00057330·Birmingham, Alabama and 74 others

CompletedAn Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes MellitusThis protocol is designed to evaluate the metabolic effects of adding exenatide, rosiglitazone, or both to an existing regimen of metformin in subjects with inadequate glycemic…NCT00135330·Phoenix, Arizona and 18 others

CompletedA Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 DiabetesThis study compares the effect of two doses of semaglutide (1.0 mg and 2.0 mg) in people with type 2 diabetes (T2D).NCT03989232·Birmingham, Alabama and 128 others

RecruitingTesting Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM TrialThis phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has…NCT06500481·Phoenix, Arizona and 57 others

Active not recruitingAZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2The purpose of this study is to measure the efficacy and safety of AZD0901 compared to Investigator's choice of therapy as 2L+ treatment for participants with advanced or…NCT06346392·Mobile, Alabama and 157 others

CompletedThe Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPDThe purpose of this 24 week study is to evaluate the spirometric lung function effect (trough FEV1) of Umeclidinium/Vilanterol 62.5/25 once daily compared to Tiotropium 18 mcg…NCT01777334·Tucson, Arizona and 69 others

CompletedRegulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement.The purpose of this study is to assess if 10 mg BAY59-7939, taken once daily as a tablet, is safe and prevents blood clot which may form after a knee replacement operation.NCT00362232·Birmingham, Alabama and 123 others

UnknownVBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock PatientsThis study is being conducted to evaluate the safety and effectiveness of VBI-S in elevating the blood pressure of septic shock patients with absolute or relative hypovolemia.NCT04257136·Chandler, Arizona and 7 others

CompletedPharmacokinetics of CVL-231 Following Single Oral Administration of Modified- and Immediate-release Formulations in Fasted and Fed Healthy ParticipantsA 2-part, crossover design, open-label treatment trial with 4 periods, 4 sequences (Part A) to evaluate MR formulations of CVL-231 and a 2 periods, 2 sequences (Part B) to…NCT05106309·Tempe, Arizona

CompletedThe ShortCut™ Study ProtocolA Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Clinical Study to Demonstrate the Safety and Effectiveness of the ShortCut™ device for splitting bioprosthetic…NCT04952909·Tucson, Arizona and 22 others

RecruitingA Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune ThrombocytopeniaThe main purpose of this study is to look at the effect (efficacy) and safety of efgartigimod IV in participants with primary immune thrombocytopenia (ITP).NCT06544499·Phoenix, Arizona and 93 others

CompletedSafety and Effectiveness of Monovisc® Injection for Osteoarthritis of the KneeThe purpose of this study is to determine whether intra-articular injection of Monovisc® hyaluronic acid provides symptomatic relief of osteoarthritis of the knee.NCT00653432·Hoover, Alabama and 30 others

CompletedA Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)This trial is to assess efficacy, safety, blood levels and bodily effects of up to 2 dose levels of intravenous (IV) pegloticase (KRYSTEXXA) infusions at every 4 week intervals…NCT04762498·Anchorage, Alaska and 11 others

PreviousPage 100 of 831Next

in Arizona

Heart Diseasein Arizona